ArticleCancer immunology, immunotherapy : CII2013

MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.

Fabricio de Carvalho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.